Patrik Eriksson

Insider

First SEC filing: Sept. 20, 2019 · Latest: Sept. 20, 2019

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 12 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

12 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Feb. 25, 2020	NVST	A	16,040	—	—	78,564 Direct	+25.65%	Acquired	(price as of 2026-08-21)
Feb. 25, 2020	NVST	A	59,210	—	—	59,210 Direct	—	Acquired	(price as of 2026-08-21)
Feb. 24, 2020	NVST	F	5,447	$27.30	$148,703	62,524 Direct	-8.01%	Disposed	-1.2% (price as of 2026-08-21)
Feb. 19, 2020	NVST	A	1,893	$28.29	$53,553	1,893 Direct	—	Acquired	-4.6% (price as of 2026-08-21)
Dec. 18, 2019	NVST	A	38,344	—	—	38,344 Direct	—	Acquired	(price as of 2026-08-21)
Dec. 18, 2019	NVST	A	38,344	—	—	38,344 Direct	—	Acquired	(price as of 2026-08-21)
Dec. 18, 2019	NVST	A	40,327	—	—	40,327 Direct	—	Acquired	(price as of 2026-08-21)
Dec. 18, 2019	NVST	A	32,240	—	—	32,240 Direct	—	Acquired	(price as of 2026-08-21)
Dec. 18, 2019	NVST	A	20,033	—	—	20,033 Direct	—	Acquired	(price as of 2026-08-21)
Dec. 18, 2019	NVST	A	14,654	—	—	14,654 Direct	—	Acquired	(price as of 2026-08-21)
Dec. 18, 2019	NVST	A	4,914	—	—	4,914 Direct	—	Acquired	(price as of 2026-08-21)
Dec. 18, 2019	NVST	A	55,016	—	—	67,971 Direct	+424.67%	Acquired	(price as of 2026-08-21)
Sept. 20, 2019	NVST	P	5,000	$22.00	$110,000	5,000 Direct	—	Acquired	22.6% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Feb. 25, 2020	NVST	Employee Stock Option (Right to Buy)	Common Stock (59,210)	$26.50	Feb. 25, 2030	59,210	Acquired
Feb. 19, 2020	NVST	Executive Deferred Incentive Program - Envista Stock Fund	Common Stock	—	—	1,893	Acquired
Dec. 18, 2019	NVST	Employee Stock Option (Right to Buy) [F3]	Common Stock (38,344)	$21.76	Feb. 24, 2029	38,344	Acquired
Dec. 18, 2019	NVST	Employee Stock Option (Right to Buy) [F3]	Common Stock (38,344)	$21.76	Feb. 24, 2029	38,344	Acquired
Dec. 18, 2019	NVST	Employee Stock Option (Right to Buy) [F3]	Common Stock (40,327)	$19.04	Feb. 24, 2028	40,327	Acquired
Dec. 18, 2019	NVST	Employee Stock Option (Right to Buy) [F3]	Common Stock (32,240)	$19.04	Feb. 24, 2028	32,240	Acquired
Dec. 18, 2019	NVST	Employee Stock Option (Right to Buy) [F3]	Common Stock (20,033)	$16.51	Feb. 24, 2027	20,033	Acquired
Dec. 18, 2019	NVST	Employee Stock Option (Right to Buy) [F3]	Common Stock (14,654)	$12.65	Feb. 24, 2026	14,654	Acquired
Dec. 18, 2019	NVST	Employee Stock Option (Right to Buy) [F3]	Common Stock (4,914)	$12.62	Feb. 24, 2025	4,914	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Sept. 20, 2019	NVST	Employee Stock Option (Right to Buy)→ Common Stock (31,820)	31,820	Direct
Sept. 20, 2019	NVST	Restricted Stock Unit→ Common Stock (7,955)	7,955	Direct

Matched by name from proxy statements (DEF 14A) — verify against the filing.

SVP and President of Nobel Biocare, until December 31, 2023

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2023	$550,000	—	$637,770	$212,626	$103,950	—	$97,260	$1,601,606
2022	$550,000	—	$637,582	$212,579	$203,088	—	$81,519	$1,684,768
2021	$550,000	—	$425,118	$425,032	$532,263	—	$86,598	$2,019,011

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.